Skip to main content
Figure 2 | BMC Structural Biology

Figure 2

From: The Host-Pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains

Figure 2

Characterization of C-terminal Vpr peptides interacting with CypA. SPR sensorgrams for synthetic Vpr75-90, the mutants Vpr75-90 (R76Q, V83I, T84I), Vpr75-90 (R76Q, V83I, R80A, T84I), Vpr75-90 (R80A) and the shorter peptides Vpr69-78, Vpr75-84, Vpr81-90 and Vpr87-96 were analyzed for binding to immobilized recombinant CypA. The peptides were injected at concentrations ranging from 0-8 μM over CM5 chip immobilized to 150 RU with CypA.

Back to article page